ICHOR HOLDINGS LTD (ICHR) Fundamental Analysis & Valuation

NASDAQ:ICHR • KYG4740B1059

Current stock price

46.81 USD
-0.81 (-1.7%)
At close:
46 USD
-0.81 (-1.73%)
Pre-Market:

This ICHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ICHR Profitability Analysis

1.1 Basic Checks

  • ICHR had positive earnings in the past year.
  • ICHR had a positive operating cash flow in the past year.
  • In multiple years ICHR reported negative net income over the last 5 years.
  • ICHR had a positive operating cash flow in each of the past 5 years.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • ICHR has a worse Return On Assets (-5.60%) than 65.22% of its industry peers.
  • The Return On Equity of ICHR (-7.95%) is worse than 66.09% of its industry peers.
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • ICHR has a Gross Margin of 11.45%. This is amonst the worse of the industry: ICHR underperforms 85.22% of its industry peers.
  • In the last couple of years the Gross Margin of ICHR has declined.
  • The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.57%
GM growth 5Y-4.81%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICHR Health Analysis

2.1 Basic Checks

  • ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ICHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ICHR has an Altman-Z score of 5.00. This indicates that ICHR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.00, ICHR is in line with its industry, outperforming 55.65% of the companies in the same industry.
  • ICHR has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.18, ICHR is in line with its industry, outperforming 48.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 5
ROIC/WACCN/A
WACC11.58%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.16 indicates that ICHR has no problem at all paying its short term obligations.
  • ICHR has a Current ratio (3.16) which is in line with its industry peers.
  • A Quick Ratio of 1.38 indicates that ICHR should not have too much problems paying its short term obligations.
  • The Quick ratio of ICHR (1.38) is worse than 77.39% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.38
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ICHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.75% over the past year.
  • The earnings per share for ICHR have been decreasing by -37.90% on average. This is quite bad
  • The Revenue has grown by 11.61% in the past year. This is quite good.
  • Measured over the past years, ICHR shows a small growth in Revenue. The Revenue has been growing by 0.72% on average per year.
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%

3.2 Future

  • Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 94.84% on average per year.
  • ICHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.14% yearly.
EPS Next Y396.7%
EPS Next 2Y207.51%
EPS Next 3Y63.75%
EPS Next 5Y94.84%
Revenue Next Year16.11%
Revenue Next 2Y14.07%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. ICHR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 203.52 indicates a quite expensive valuation of ICHR.
  • The rest of the industry has a similar Price/Earnings ratio as ICHR.
  • Compared to an average S&P500 Price/Earnings ratio of 25.79, ICHR is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 40.98, the valuation of ICHR can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICHR is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, ICHR is valued quite expensively.
Industry RankSector Rank
PE 203.52
Fwd PE 40.98
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ICHR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 78.29
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ICHR's earnings are expected to grow with 63.75% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y207.51%
EPS Next 3Y63.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICHR Dividend Analysis

5.1 Amount

  • ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICHR Fundamentals: All Metrics, Ratios and Statistics

ICHOR HOLDINGS LTD

NASDAQ:ICHR (3/18/2026, 8:14:49 PM)

Premarket: 46 -0.81 (-1.73%)

46.81

-0.81 (-1.7%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners101.06%
Inst Owner Change0.44%
Ins Owners1.6%
Ins Owner Change11.96%
Market Cap1.62B
Revenue(TTM)947.65M
Net Income(TTM)-52.78M
Analysts78.46
Price Target47.79 (2.09%)
Short Float %6.31%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.67%
Min EPS beat(2)-42.12%
Max EPS beat(2)117.46%
EPS beat(4)1
Avg EPS beat(4)-14.74%
Min EPS beat(4)-79.27%
Max EPS beat(4)117.46%
EPS beat(8)3
Avg EPS beat(8)-563.34%
EPS beat(12)5
Avg EPS beat(12)-364.79%
EPS beat(16)7
Avg EPS beat(16)-272.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.48%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)-0.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)3
Avg Revenue beat(8)-0.37%
Revenue beat(12)6
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)-0.11%
PT rev (1m)55.45%
PT rev (3m)96.6%
EPS NQ rev (1m)84.34%
EPS NQ rev (3m)61.9%
EPS NY rev (1m)42.29%
EPS NY rev (3m)38.56%
Revenue NQ rev (1m)5.81%
Revenue NQ rev (3m)8.02%
Revenue NY rev (1m)9.17%
Revenue NY rev (3m)10.03%
Valuation
Industry RankSector Rank
PE 203.52
Fwd PE 40.98
P/S 1.71
P/FCF N/A
P/OCF 54.26
P/B 2.44
P/tB 5.63
EV/EBITDA 78.29
EPS(TTM)0.23
EY0.49%
EPS(NY)1.14
Fwd EY2.44%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.86
OCFY1.84%
SpS27.36
BVpS19.17
TBVpS8.32
PEG (NY)0.51
PEG (5Y)N/A
Graham Number9.96
Profitability
Industry RankSector Rank
ROA -5.6%
ROE -7.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.45%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.57%
GM growth 5Y-4.81%
F-Score3
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 5.58
Cap/Depr 107.95%
Cap/Sales 3.82%
Interest Coverage N/A
Cash Conversion 142.09%
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.38
Altman-Z 5
F-Score3
WACC11.58%
ROIC/WACCN/A
Cap/Depr(3y)70.04%
Cap/Depr(5y)74.83%
Cap/Sales(3y)2.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.75%
EPS 3Y-60.1%
EPS 5Y-37.9%
EPS Q2Q%-87.5%
EPS Next Y396.7%
EPS Next 2Y207.51%
EPS Next 3Y63.75%
EPS Next 5Y94.84%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y-9.54%
Revenue growth 5Y0.72%
Sales Q2Q%-4.15%
Revenue Next Year16.11%
Revenue Next 2Y14.07%
Revenue Next 3Y11.53%
Revenue Next 5Y13.14%
EBIT growth 1Y-63.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year697.58%
EBIT Next 3Y88.46%
EBIT Next 5Y99.45%
FCF growth 1Y-161.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.2%
OCF growth 3Y-1.69%
OCF growth 5Y-4.82%

ICHOR HOLDINGS LTD / ICHR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


Can you provide the valuation status for ICHOR HOLDINGS LTD?

ChartMill assigns a valuation rating of 3 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the financial health of ICHOR HOLDINGS LTD (ICHR) stock?

The financial health rating of ICHOR HOLDINGS LTD (ICHR) is 4 / 10.